Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Adenocarcinoma × nintedanib × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Genitourinary 1

Conditions

Prostatic Neoplasms 3 Uterine Cervical Neoplasms 1 Endometrial Adenocarcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma, Renal Cell 1

Interventions

nintedanib 1 brivanib 1 ALK1-Fc fusion protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01225887 2017-10-09

Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer

GOG Foundation

Phase 2 Completed

37 enrolled 11 charts

GenitourinaryGynecologic

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡